Vol 10, No 1 (2017)
Prace poglądowe
Published online: 2017-03-29
Treatment of autosomal dominant polycystic kidney disease — current status
Forum Nefrologiczne 2017;10(1):10-15.
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetically determined kidney disease, with an incidence of 1:1000 births. 10% of end stage renal disease that require renal replacement therapy is caused by ADPKD. The aim of this paper is to review current status of treatment and management of ADPKD patients.
Keywords: autosomal dominant polycystic kidney diseasedrug therapytolvaptanend stage renal diseasearterial hypertensionrenal replacement therapy
